SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-10 - Registration Statement for Securities of certain Canadian Issuers.:
SEC Accession No. 0001193125-23-215034
Filing Date
2023-08-17
Accepted
2023-08-17 16:06:13
Documents
9

Document Format Files

Seq Description Document Type Size
1 F-10 d481183df10.htm F-10 277055
2 EX-5.1 d481183dex51.htm EX-5.1 2522
3 EX-5.2 d481183dex52.htm EX-5.2 2713
4 EX-7.1 d481183dex71.htm EX-7.1 293637
5 EX-7.2 d481183dex72.htm EX-7.2 296277
6 EX-FILING FEES d481183dexfilingfees.htm EX-FILING FEES 52318
7 GRAPHIC g481183g04y51.jpg GRAPHIC 20439
8 GRAPHIC g481183g0816103725697.jpg GRAPHIC 2914
9 GRAPHIC g481183g35d07.jpg GRAPHIC 34619
  Complete submission text file 0001193125-23-215034.txt   1005679
Mailing Address 400 W ERIE ST SUITE 110 CHICAGO IL 60654
Business Address 400 W ERIE ST SUITE 110 CHICAGO IL 60654 (312) 929-0993
Cresco Labs Inc. (Filer) CIK: 0001832928 (see all company filings)

IRS No.: 981505364 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: F-10 | Act: 33 | File No.: 333-274047 | Film No.: 231181907
SIC: 2833 Medicinal Chemicals & Botanical Products